Navigation Links
BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels
Date:5/19/2009

3-Year Study Highlights the Clinical Success of Dental Implants with Laser-Lok(R) Technology over Traditional Implants

BIRMINGHAM, Ala., May 19 /PRNewswire/ -- BioHorizons, a leader in the dental implant industry, reported today that data from a three-year prospective, controlled, multi-center study of implants with Laser-Lok(R) surface treatment confirmed previous results observed for Laser-Lok in vitro and in animal studies. Laser-Lok implants showed superior crestal bone maintenance when compared to traditional implants and to bone loss commonly reported in other studies.

"A physical, connective tissue attachment to dental implants was shown for the first time in human and animal studies on Laser-Lok published last year," commented Dr. John L. Ricci, PhD. "This latest study shows the clinical benefits of a physical connective tissue attachment to Laser-Lok are significant when compared to the typical 1.5-2mm of bone loss documented with other implants."

The study, published in Implant Dentistry, followed 20 pairs of implants in 15 patients from 1 to 37 months postoperative. A dental implant with Laser-Lok surface treatment was placed adjacent to a control implant of the same body design without Laser-Lok. Measurement values were reported for bleeding index, plaque index, probing depth, and crestal bone loss.

At 37 months, the mean probing depth was 3.60mm and the mean crestal bone loss was 1.94mm for the control implants versus only 2.30mm and 0.59mm, respectively, for the Laser-Lok implants. The difference in probing depth across the patient population demonstrated the consistent formation of a stable soft-tissue seal around the Laser-Lok implants and above the crestal bone. In addition, no difference in bleeding or plaque index between the Laser-Lok implants and the machined implants was shown, alleviating possible concerns about placing Laser-Lok implants supracrestal.

Steve Boggan, President and CEO of BioHorizons, added, "This study provides valuable information about the positive, long-term outcomes of dental implants with Laser-Lok microchannels and confirms what our customers have been telling us for some time."

The effectiveness of Laser-Lok has been shown in over 15 years of in vitro, animal, and human studies at leading universities. This patented precision laser surface treatment is unique within the industry as the only surface treatment shown to attract a physical connective tissue attachment to a predetermined zone on the implant while inhibiting epithelial downgrowth and preserving the coronal level of bone over the long term.

1) Human Histologic Evidence of a Connective Tissue Attachment to a Dental Implant. M Nevins, ML Nevins, M Camelo, JL Boyesen, DM Kim. The International Journal of Periodontics & Restorative Dentistry. Vol. 28, No. 2, 2008. 2) The Effects of Laser Microtextured Collars Upon Crestal Bone Levels of Dental Implants. S Weiner, J Simon, DS Ehrenberg, B Zweig, and JL Ricci. Implant Dentistry, Volume 17, Number 2, 2008. p. 217-228. 3) Clinical Evaluation of Laser Microtexturing for Soft Tissue and Bone Attachment to Dental Implants. G. E. Pecora, R. Ceccarelli, M. Bonelli, H. Alexander, J.L. Ricci. Implant Dentistry: Vol. 18, No. 1, February 2009, pp 57-66. 4) Clinical References available.

About BioHorizons, Inc.

BioHorizons is a leading oral reconstructive device company at the forefront of digital dentistry. The company has a broad product offering, including dental implants, surgical planning software, regenerative products, CAD/CAM and traditional dental restorations. BioHorizons has a direct sales force in the USA, Canada, Spain, United Kingdom, Germany, Australia and Chile. Products are distributed in the rest of the world via a network of independent distributors. For more information, visit www.biohorizons.com.


'/>"/>
SOURCE BioHorizons, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BioHorizons Introduces Its New Tapered Internal Implants Featuring Laser-Lok(R) Microgrooves
2. BioHorizons Expands to New 44,000 Square Foot Facility
3. Osteotech Engages BioHorizons as Exclusive Distributor to International Dental Market
4. BioHorizons Announces Its 2009 Global Symposium: Bringing Together Top Thought Leaders in the Dental Implant Industry to Provide Insight on Integrating Technology into the Continuum of Care
5. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
6. Haemacure Reports Third Quarter 2007 Results
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
11. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to ... and other developmental disabilities. The group, which is being launched with the help of ... to share stories and advice, seek help, and continue their education on how to ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. ... will be included in the 2016 “Guide to America’s Top Plastic Surgeons” for ... the amalgamation of their education, experience, and professional associations. , One the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... diagnostic imaging systems and the first company to offer robotic imaging to ... at their tradeshow booth # 941 for the American Association of Equine Practitioners ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... announce that we have been designated as a Cigna Infertility Center of Excellence. ... rigorous performance standards. , “It’s an honor to be designated a Cigna ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Research and Markets has announced the addition of ... Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer drugs ... according to organs involved and the types of cancer as well ...
(Date:12/2/2016)... Conn. , Dec. 1, 2016  Today, Simpson ... announced the honor of being selected as winners of ... Simpson Healthcare Executives Website at the PLATINUM level, Blue ... Training Module at the GOLD Level, and our proprietary ... At Simpson Healthcare Executives, we are excited to ...
(Date:12/2/2016)... Dec. 2, 2016  UCB is pleased to announce that 12 ... upcoming 70 th American Epilepsy Society (AES) Annual Meeting, ... TX , USA. 1-12 Data ... profile of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... on the current state of the union of epilepsy care ...
Breaking Medicine Technology: